Results 211 to 220 of about 145,462 (315)

β-Lactam vs Non-β-Lactam Prophylaxis in Elective Colorectal Surgery.

JAMA Netw Open
Collins CD, Hartsfield E, Cleary RK, Veve MP, Brockhaus KK.   +4 more
europepmc   +1 more source

Acquired resistance in Stenotrophomonas maltophilia: Mechanisms underlying the shift from multidrug to pandrug resistance. [PDF]

Eur J Microbiol Immunol (Bp)
Vattanaviboon P, Dulyayangkul P, Tipanyo P, Mongkolsuk S, Charoenlap N.   +4 more
europepmc   +1 more source

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection model. [PDF]

Antimicrob Agents Chemother
Singh N, Jogan CML, Zang Y, Shan X, Lang Y, Karunanidhi A, Watkins JV, Curry BN, Tamma PD, Nozick SH, Ozer EA, Hauser AR, Bulitta JB, Bulman ZP.   +13 more
europepmc   +1 more source

Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl- polyethylenimine -containing nanoplexes.

International journal of pharmaceutics, 2017
Fatemeh Oroojalian, A. Rezayan, W. Shier, K. Abnous, M. Ramezani   +4 more
semanticscholar   +1 more source

Pharmacologic Inhibition of JAK1/2 Potentiates Aminoglycoside-Induced Ototoxicity. [PDF]

Otol Neurotol
Fleegel J, Ezzat I, Vijayakumar S, Zallocchi M, Zuo J.   +4 more
europepmc   +1 more source

Aminoglycoside Drugs as Adjuvants to Enhance siRNA/mRNA Delivery by Lipid Nanoparticles. [PDF]

ACS Omega
Sun X, Qian L.
europepmc   +1 more source

Silver potentiates aminoglycoside toxicity by enhancing their uptake

Molecular Microbiology, 2017
Marion Hérisse, Yohann Duverger, I. Martin-Verstraete, F. Barras, B. Ezraty   +4 more
semanticscholar   +1 more source

Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief Summary. [PDF]

Open Forum Infect Dis
Bhavnani SM, Hammel JP, Onufrak NJ, Pogue JM, Jones RN, Sader HS, Drusano GL, Bradley JS, Andes DR, Craig WA, Ambrose PG.   +10 more
europepmc   +1 more source

Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. [PDF]

New Microbes New Infect
Hongler J, Haller S, Adakun AS, Lutz N, Buzibye A, Kälin M, Castelnuovo B, Sekaggya-Wiltshire C, Abongomera G, Jetter A, Fehr J.   +10 more
europepmc   +1 more source